OcuHealth, an emerging eye therapeutics start-up, was named overall winner of University College Dublin’s (UCD) VentureLaunch Accelerator Programme for 2025. The joint UCD and South East Technological University (SETU) project received €700,000 through the Enterprise Ireland Commercialisation Fund and is already being supported by technology transfer offices at SETU and NovaUCD.
The company is developing novel formulations to treat eye disease in the form of a daily eyedrop that can deliver conventional small molecules and large biomolecules, in a slow and sustained manner, to all parts of the eye, substantially improving on current treatment options.
While OcuHealth’s platform technology could be used to treat many different eye diseases, its initial target is dry eye disease, a common condition involving pain, inflammation and irritation at the surface of the eye.
Full story: Ocular therapeutics start-up wins VentureLaunch Award – TechCentral.ie
